Sign up to save your podcasts
Or
Share Ep. 16 - Breaking Barriers: Discovering the True Cause of Trauma and Challenging Traditional Treatment Methods
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Ep. 16 - Breaking Barriers: Discovering the True Cause of Trauma and Challenging Traditional Treatment Methods
In our latest episode of the Bring It On Home podcast, Cody and Daniel give a weekly update on the psychedelic industry and how quickly it is evolving with 5 companies now holding FDA BREAKTHROUGH THERAPY DESIGNATIONS for 5 different compounds. Compass Pathways with synthetic psilocybin to treat treatment resistant depression, Usona with synthetic psilocybin to treat major depressive disorder, Cybin with synthetic psilocybin to major depressive disorder, Mindmed with LSD to treat anxiety disorders, and Lykos Therapeutics with MDMA to treat PTSD. These emerging medicines get to the root cause of someone's issues and allow them to move past their trauma so it does not govern the rest of their life.
View all episodes
By Daniel and CodyIn our latest episode of the Bring It On Home podcast, Cody and Daniel give a weekly update on the psychedelic industry and how quickly it is evolving with 5 companies now holding FDA BREAKTHROUGH THERAPY DESIGNATIONS for 5 different compounds. Compass Pathways with synthetic psilocybin to treat treatment resistant depression, Usona with synthetic psilocybin to treat major depressive disorder, Cybin with synthetic psilocybin to major depressive disorder, Mindmed with LSD to treat anxiety disorders, and Lykos Therapeutics with MDMA to treat PTSD. These emerging medicines get to the root cause of someone's issues and allow them to move past their trauma so it does not govern the rest of their life.